GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » EV-to-EBITDA

Bayer AG (XTER:BAYN) EV-to-EBITDA

: 5.56 (As of Today)
View and export this data going back to 1953. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bayer AG's enterprise value is €58,066 Mil. Bayer AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €10,444 Mil. Therefore, Bayer AG's EV-to-EBITDA for today is 5.56.

The historical rank and industry rank for Bayer AG's EV-to-EBITDA or its related term are showing as below:

XTER:BAYN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -51.87   Med: 7.63   Max: 16.16
Current: 5.56

During the past 13 years, the highest EV-to-EBITDA of Bayer AG was 16.16. The lowest was -51.87. And the median was 7.63.

XTER:BAYN's EV-to-EBITDA is ranked better than
87.25% of 706 companies
in the Drug Manufacturers industry
Industry Median: 13.805 vs XTER:BAYN: 5.56

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-19), Bayer AG's stock price is €26.24. Bayer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-2.990. Therefore, Bayer AG's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bayer AG EV-to-EBITDA Historical Data

The historical data trend for Bayer AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.45 -32.21 12.11 6.05 6.27

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.05 4.11 3.58 3.26 6.27

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG EV-to-EBITDA Distribution

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bayer AG's EV-to-EBITDA falls into.



Bayer AG EV-to-EBITDA Calculation

Bayer AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=58065.808/10444
=5.56

Bayer AG's current Enterprise Value is €58,066 Mil.
Bayer AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €10,444 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG  (XTER:BAYN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bayer AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=26.24/-2.990
=At Loss

Bayer AG's share price for today is €26.24.
Bayer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.990.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bayer AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bayer AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (XTER:BAYN) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (XTER:BAYN) Headlines